Hyperphosphatemia in a patient with Candida sepsis
At admission, he had normal calcium, phosphate, and magnesium but developed persistent hyperphosphatemia (phosphotungstate on Beckman DCxI) with values of 5 to 6.5 mg/dL (reference interval 2.5-4.5 mg/dl) despite only mild, stable renal dysfunction [normal blood urea nitrogen, creatinine 1.5-1.9 mg/...
Gespeichert in:
| Veröffentlicht in: | Clinical chemistry (Baltimore, Md.) Md.), 2014-09, Vol.60 (9), p.1241-1242 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1242 |
|---|---|
| container_issue | 9 |
| container_start_page | 1241 |
| container_title | Clinical chemistry (Baltimore, Md.) |
| container_volume | 60 |
| creator | Dufour, D Robert |
| description | At admission, he had normal calcium, phosphate, and magnesium but developed persistent hyperphosphatemia (phosphotungstate on Beckman DCxI) with values of 5 to 6.5 mg/dL (reference interval 2.5-4.5 mg/dl) despite only mild, stable renal dysfunction [normal blood urea nitrogen, creatinine 1.5-1.9 mg/dL (reference interval 0.8-1.5 mg/dL)] and continued normal calcium. Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article. |
| doi_str_mv | 10.1373/clinchem.2013.220087 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1558516903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3465637021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-7c67778420d6184817cb536baeb846136baa21dd6aea062ad9ff0ee453078c923</originalsourceid><addsrcrecordid>eNpdkE1Lw0AQhhdRbK3-A5GAFy-pM7ub3c1RSrVCwYuel81mQ7bky2yC9N-b0taDp5mB5x1eHkLuEZbIJHu2lW9s6eolBWRLSgGUvCBzTBjEKhF4SeYAkMYpcjkjNyHsppNLJa7JjCYoAYWaE7rZd67vyjZ0pRlc7U3km8hEnRm8a4boxw9ltDJN7nMTBdcFH27JVWGq4O5Oc0G-Xtefq028_Xh7X71sY8sUDrG0QkqpOIVcoOIKpc0SJjLjMsUFHjZDMc-FcQYENXlaFOAcn_pLZVPKFuTp-Lfr2-_RhUHXPlhXVaZx7Rg0JolKUKTAJvTxH7prx76Z2mkUyIFPVdKJ4kfK9m0IvSt01_va9HuNoA9O9dmpPjjVR6dT7OH0fMxql_-FzhLZL9Hocmk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1614046779</pqid></control><display><type>article</type><title>Hyperphosphatemia in a patient with Candida sepsis</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Dufour, D Robert</creator><creatorcontrib>Dufour, D Robert</creatorcontrib><description>At admission, he had normal calcium, phosphate, and magnesium but developed persistent hyperphosphatemia (phosphotungstate on Beckman DCxI) with values of 5 to 6.5 mg/dL (reference interval 2.5-4.5 mg/dl) despite only mild, stable renal dysfunction [normal blood urea nitrogen, creatinine 1.5-1.9 mg/dL (reference interval 0.8-1.5 mg/dL)] and continued normal calcium. Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1373/clinchem.2013.220087</identifier><identifier>PMID: 25170168</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Amphotericin B - adverse effects ; Amphotericin B - therapeutic use ; Antifungal Agents - adverse effects ; Antifungal Agents - therapeutic use ; Blood Chemical Analysis ; Calcium ; Candida - isolation & purification ; Candidiasis - complications ; Candidiasis - drug therapy ; Fluconazole - therapeutic use ; Humans ; Hyperphosphatemia - complications ; Hyperphosphatemia - etiology ; Magnesium ; Male ; Middle Aged ; Renal function ; Sepsis ; Sepsis - complications ; Sepsis - drug therapy ; Urea</subject><ispartof>Clinical chemistry (Baltimore, Md.), 2014-09, Vol.60 (9), p.1241-1242</ispartof><rights>Copyright American Association for Clinical Chemistry Sep 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-7c67778420d6184817cb536baeb846136baa21dd6aea062ad9ff0ee453078c923</citedby><cites>FETCH-LOGICAL-c381t-7c67778420d6184817cb536baeb846136baa21dd6aea062ad9ff0ee453078c923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25170168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dufour, D Robert</creatorcontrib><title>Hyperphosphatemia in a patient with Candida sepsis</title><title>Clinical chemistry (Baltimore, Md.)</title><addtitle>Clin Chem</addtitle><description>At admission, he had normal calcium, phosphate, and magnesium but developed persistent hyperphosphatemia (phosphotungstate on Beckman DCxI) with values of 5 to 6.5 mg/dL (reference interval 2.5-4.5 mg/dl) despite only mild, stable renal dysfunction [normal blood urea nitrogen, creatinine 1.5-1.9 mg/dL (reference interval 0.8-1.5 mg/dL)] and continued normal calcium. Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.</description><subject>Amphotericin B - adverse effects</subject><subject>Amphotericin B - therapeutic use</subject><subject>Antifungal Agents - adverse effects</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Blood Chemical Analysis</subject><subject>Calcium</subject><subject>Candida - isolation & purification</subject><subject>Candidiasis - complications</subject><subject>Candidiasis - drug therapy</subject><subject>Fluconazole - therapeutic use</subject><subject>Humans</subject><subject>Hyperphosphatemia - complications</subject><subject>Hyperphosphatemia - etiology</subject><subject>Magnesium</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Renal function</subject><subject>Sepsis</subject><subject>Sepsis - complications</subject><subject>Sepsis - drug therapy</subject><subject>Urea</subject><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkE1Lw0AQhhdRbK3-A5GAFy-pM7ub3c1RSrVCwYuel81mQ7bky2yC9N-b0taDp5mB5x1eHkLuEZbIJHu2lW9s6eolBWRLSgGUvCBzTBjEKhF4SeYAkMYpcjkjNyHsppNLJa7JjCYoAYWaE7rZd67vyjZ0pRlc7U3km8hEnRm8a4boxw9ltDJN7nMTBdcFH27JVWGq4O5Oc0G-Xtefq028_Xh7X71sY8sUDrG0QkqpOIVcoOIKpc0SJjLjMsUFHjZDMc-FcQYENXlaFOAcn_pLZVPKFuTp-Lfr2-_RhUHXPlhXVaZx7Rg0JolKUKTAJvTxH7prx76Z2mkUyIFPVdKJ4kfK9m0IvSt01_va9HuNoA9O9dmpPjjVR6dT7OH0fMxql_-FzhLZL9Hocmk</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Dufour, D Robert</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7QO</scope><scope>7RV</scope><scope>7TM</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20140901</creationdate><title>Hyperphosphatemia in a patient with Candida sepsis</title><author>Dufour, D Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-7c67778420d6184817cb536baeb846136baa21dd6aea062ad9ff0ee453078c923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Amphotericin B - adverse effects</topic><topic>Amphotericin B - therapeutic use</topic><topic>Antifungal Agents - adverse effects</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Blood Chemical Analysis</topic><topic>Calcium</topic><topic>Candida - isolation & purification</topic><topic>Candidiasis - complications</topic><topic>Candidiasis - drug therapy</topic><topic>Fluconazole - therapeutic use</topic><topic>Humans</topic><topic>Hyperphosphatemia - complications</topic><topic>Hyperphosphatemia - etiology</topic><topic>Magnesium</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Renal function</topic><topic>Sepsis</topic><topic>Sepsis - complications</topic><topic>Sepsis - drug therapy</topic><topic>Urea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dufour, D Robert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dufour, D Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperphosphatemia in a patient with Candida sepsis</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><addtitle>Clin Chem</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>60</volume><issue>9</issue><spage>1241</spage><epage>1242</epage><pages>1241-1242</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>At admission, he had normal calcium, phosphate, and magnesium but developed persistent hyperphosphatemia (phosphotungstate on Beckman DCxI) with values of 5 to 6.5 mg/dL (reference interval 2.5-4.5 mg/dl) despite only mild, stable renal dysfunction [normal blood urea nitrogen, creatinine 1.5-1.9 mg/dL (reference interval 0.8-1.5 mg/dL)] and continued normal calcium. Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>25170168</pmid><doi>10.1373/clinchem.2013.220087</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-9147 |
| ispartof | Clinical chemistry (Baltimore, Md.), 2014-09, Vol.60 (9), p.1241-1242 |
| issn | 0009-9147 1530-8561 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1558516903 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Amphotericin B - adverse effects Amphotericin B - therapeutic use Antifungal Agents - adverse effects Antifungal Agents - therapeutic use Blood Chemical Analysis Calcium Candida - isolation & purification Candidiasis - complications Candidiasis - drug therapy Fluconazole - therapeutic use Humans Hyperphosphatemia - complications Hyperphosphatemia - etiology Magnesium Male Middle Aged Renal function Sepsis Sepsis - complications Sepsis - drug therapy Urea |
| title | Hyperphosphatemia in a patient with Candida sepsis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A03%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperphosphatemia%20in%20a%20patient%20with%20Candida%20sepsis&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Dufour,%20D%20Robert&rft.date=2014-09-01&rft.volume=60&rft.issue=9&rft.spage=1241&rft.epage=1242&rft.pages=1241-1242&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1373/clinchem.2013.220087&rft_dat=%3Cproquest_cross%3E3465637021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1614046779&rft_id=info:pmid/25170168&rfr_iscdi=true |